# Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.

> **NCT07416240** · EARLY_PHASE1 · RECRUITING · sponsor: **Hainan Cancer Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Advanced Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** Claudin18.2 Targeted Activated Dendritic Cells
- **BIOLOGICAL:** Claudin18.2 Targeted CAR-T Cells

## Key facts

- **NCT ID:** NCT07416240
- **Lead sponsor:** Hainan Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-18
- **Primary completion:** 2028-02-18
- **Final completion:** 2028-08-18
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07416240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07416240, "Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07416240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*